Brief Introduction and Comment on the Final Revised Vision of Botanical Drug Development Guidance for Industry Issued by FDA

WANG Zhi-min, LIU Bao-yan, WANG Hai-nan, LIU Xiao-qian, GAO Hui-min

Chinese Pharmaceutical Journal ›› 2017, Vol. 52 ›› Issue (11) : 905-909.

PDF(1144 KB)
PDF(1144 KB)
Chinese Pharmaceutical Journal ›› 2017, Vol. 52 ›› Issue (11) : 905-909. DOI: 10.11669/cpj.2017.11.001
CONTENT

Brief Introduction and Comment on the Final Revised Vision of Botanical Drug Development Guidance for Industry Issued by FDA

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2017, 52(11): 905-909 https://doi.org/10.11669/cpj.2017.11.001

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1144 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉